Citadel Advisors’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-23,000
| Closed | -$284K | – | 12792 |
|
|
2025
Q3 | $284K | Sell |
23,000
-36,300
| -61% | -$426K | ﹤0.01% | 10497 |
|
|
2025
Q2 | $683K | Buy |
59,300
+47,900
| +420% | +$568K | ﹤0.01% | 7897 |
|
|
2025
Q1 | $171K | Buy |
11,400
+900
| +9% | +$15.1K | ﹤0.01% | 10672 |
|
|
2024
Q4 | $182K | Sell |
10,500
-700
| -6% | -$13.5K | ﹤0.01% | 10601 |
|
|
2024
Q3 | $208K | Buy |
11,200
+4,700
| +72% | +$94.4K | ﹤0.01% | 10070 |
|
|
2024
Q2 | $132K | Sell |
6,500
-9,200
| -59% | -$163K | ﹤0.01% | 10529 |
|
|
2024
Q1 | $268K | Sell |
15,700
-7,000
| -31% | -$110K | ﹤0.01% | 9715 |
|
|
2023
Q4 | $401K | Buy |
22,700
+12,100
| +114% | +$244K | ﹤0.01% | 8567 |
|
|
2023
Q3 | $255K | Buy |
10,600
+7,200
| +212% | +$177K | ﹤0.01% | 9469 |
|
|
2023
Q2 | $79K | Sell |
3,400
-2,800
| -45% | -$63.3K | ﹤0.01% | 11265 |
|
|
2023
Q1 | $137K | Sell |
6,200
-14,900
| -71% | -$349K | ﹤0.01% | 10791 |
|
|
2022
Q4 | $428K | Buy |
21,100
+6,100
| +41% | +$118K | ﹤0.01% | 8567 |
|
|
2022
Q3 | $202K | Sell |
15,000
-8,300
| -36% | -$140K | ﹤0.01% | 10380 |
|
|
2022
Q2 | $462K | Buy |
23,300
+11,900
| +104% | +$316K | ﹤0.01% | 8819 |
|
|
2022
Q1 | $361K | Sell |
11,400
-2,200
| -16% | -$61.7K | ﹤0.01% | 10162 |
|
|
2021
Q4 | $303K | Sell |
13,600
-5,900
| -30% | -$154K | ﹤0.01% | 10895 |
|
|
2021
Q3 | $541K | Buy |
19,500
+3,100
| +19% | +$94.4K | ﹤0.01% | 9669 |
|
|
2021
Q2 | $639K | Buy |
16,400
+8,200
| +100% | +$294K | ﹤0.01% | 9458 |
|
|
2021
Q1 | $236K | Sell |
8,200
-20,300
| -71% | -$693K | ﹤0.01% | 11371 |
|
|
2020
Q4 | $756K | Buy |
28,500
+500
| +2% | +$10.2K | ﹤0.01% | 7371 |
|
|
2020
Q3 | $427K | Buy |
28,000
+3,100
| +12% | +$65K | ﹤0.01% | 7556 |
|
|
2020
Q2 | $506K | Buy |
24,900
+6,800
| +38% | +$122K | ﹤0.01% | 7051 |
|
|
2020
Q1 | $187K | Sell |
18,100
-49,100
| -73% | -$1.37M | ﹤0.01% | 8075 |
|
|
2019
Q4 | $2.53M | Buy |
67,200
+8,000
| +14% | +$359K | ﹤0.01% | 4039 |
|
|
2019
Q3 | $2.76M | Sell |
59,200
-46,700
| -44% | -$2.17M | ﹤0.01% | 3985 |
|
|
2019
Q2 | $5.54M | Buy |
105,900
+75,100
| +244% | +$4.4M | ﹤0.01% | 2952 |
|
|
2019
Q1 | $2.12M | Buy |
30,800
+9,800
| +47% | +$657K | ﹤0.01% | 4367 |
|
|
2018
Q4 | $1.25M | Sell |
21,000
-3,000
| -13% | -$259K | ﹤0.01% | 4950 |
|
|
2018
Q3 | $2.78M | Sell |
24,000
-19,100
| -44% | -$2.15M | ﹤0.01% | 3854 |
|
|
2018
Q2 | $5.44M | Buy |
43,100
+23,300
| +118% | +$2.84M | ﹤0.01% | 2650 |
|
|
2018
Q1 | $2.14M | Buy |
19,800
+10,300
| +108% | +$1.14M | ﹤0.01% | 3630 |
|
|
2017
Q4 | $1.04M | Sell |
9,500
-12,500
| -57% | -$1.25M | ﹤0.01% | 4599 |
|
|
2017
Q3 | $2.17M | Buy |
22,000
+4,200
| +24% | +$407K | ﹤0.01% | 3319 |
|
|
2017
Q2 | $1.8M | Buy |
17,800
+10,000
| +128% | +$1.08M | ﹤0.01% | 3308 |
|
|
2017
Q1 | $901K | Sell |
7,800
-10,200
| -57% | -$1.19M | ﹤0.01% | 4163 |
|
|
2016
Q4 | $2.16M | Sell |
18,000
-1,200
| -6% | -$133K | ﹤0.01% | 2858 |
|
|
2016
Q3 | $2.16M | Sell |
19,200
-16,100
| -46% | -$1.85M | ﹤0.01% | 2884 |
|
|
2016
Q2 | $4.37M | Sell |
35,300
-10,100
| -22% | -$1.22M | ﹤0.01% | 1932 |
|
|
2016
Q1 | $5.1M | Buy |
45,400
+24,300
| +115% | +$2.52M | 0.01% | 1753 |
|
|
2015
Q4 | $2.29M | Sell |
21,100
-3,100
| -13% | -$355K | ﹤0.01% | 2595 |
|
|
2015
Q3 | $2.42M | Sell |
24,200
-4,400
| -15% | -$479K | ﹤0.01% | 2715 |
|
|
2015
Q2 | $3.26M | Sell |
28,600
-3,300
| -10% | -$400K | ﹤0.01% | 2500 |
|
|
2015
Q1 | $3.33M | Buy |
31,900
+2,900
| +10% | +$309K | ﹤0.01% | 2468 |
|
|
2014
Q4 | $3.49M | Buy |
29,000
+3,900
| +16% | +$512K | ﹤0.01% | 2322 |
|
|
2014
Q3 | $3.67M | Buy |
25,100
+8,900
| +55% | +$1.37M | ﹤0.01% | 2263 |
|
|
2014
Q2 | $2.71M | Buy |
16,200
+3,000
| +23% | +$534K | ﹤0.01% | 2446 |
|
|
2014
Q1 | $2.62M | Sell |
13,200
-2,700
| -17% | -$510K | ﹤0.01% | 2377 |
|
|
2013
Q4 | $3.04M | Sell |
15,900
-500
| -3% | -$93.1K | ﹤0.01% | 2132 |
|
|
2013
Q3 | $2.77M | Buy |
16,400
+9,300
| +131% | +$1.44M | ﹤0.01% | 2096 |
|
|
2013
Q2 | $1.08M | Buy |
+7,100
| New | +$1.01M | ﹤0.01% | 3122 |
|
Other funds holding CLB
AI
DGI
CAMG
VCM
VPM
Citadel Advisors's CLB Position: Q1 2026 in Review
Citadel Advisors increased its Core Laboratories (CLB) stake by 319% in Q1 2026, buying an estimated $2.11M and bringing the position to 154,800 shares worth $2.6M. The position accounts for ﹤0.01% of the portfolio, ranked #5541.
Citadel Advisors first reported a position in CLB in Q2 2013 and has held it in 46 quarters since. The position peaked at $44.3M in Q1 2019. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.
- Citadel Advisors held 154,800 shares of Core Laboratories worth $2.6M as of Q1 2026.
- Citadel Advisors bought 117,867 Core Laboratories shares in Q1 2026, an estimated $2.11M.
- Core Laboratories made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5541 holding.
- Citadel Advisors first reported a position in Core Laboratories in Q2 2013 and has held it in 46 quarters since.
- Citadel Advisors's Core Laboratories position peaked at $44.3M in Q1 2019.
- 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.